initially reported by Stiff et al 1 in 1983. Makino et al 2 modified this method and evaluated its clinical use for peripheral blood stem cell transplantation (PBSCT) in 1991. A simplified method for cryopreservation at −80؇C of peripheral blood stem cells (PBSC) has been increasThey reported that rates of CFU-GM remained at more than 70% during 18 months of cryopreservation and that rapid ingly used for autologous PBSC transplantation in Japan. Although this method, using 6% hydroxyethyl and sustained trilineage engraftment was obtained in 10 patients who received marrow-ablative chemotherapy and starch (HES) and 5% dimethyl sulfoxide (DMSO) as a cryoprotectant without rate-controlled freezing, has sevautotransplantation of PBSC cryopreserved by this method. While this simplified method has several advantages eral advantages over the conventional method using 10% DMSO with rate-controlled freezing, little is such as being a quick and inexpensive procedure and less clumping of the thawed cells compared with the convenknown about effects of long-term cryopreservation for years and thawing process on hematopoietic progenitional method using rate-controlled freezing with 10% DMSO and storage in liquid nitrogen, 2 little is known about tors. We examined the recovery rates of BFU-E and CFU-GM in sample tubes cryopreserved by the simplithe influence of long-term cryopreservation for years and of the thawing process on frozen-thawed hematopoietic fied method under various conditions as follows: (1) long-term storage for 1-5 years; (2) DMSO exposure stem cells. In order to assess the clinical efficacy of this simplified for 1 h after rapid thawing; and (3) thawing at a lower temperature other than 37؇C. In our study, we found method, we investigated effects of long-term cryopreservation (1-5 years), exposure of frozen-thawed cells to that the recovery rates of BFU-E and CFU-GM were not affected by the length of cryopreservation period; DMSO, and slow thawing at room temperature on hematopoietic activity of PBSC when they were cryopreserved by they remained at more than 70% on average for 16-61 months. In our hands, a 1-h exposure to DMSO after this method. rapid thawing was not toxic for hematopoietic progenitors. Furthermore, there was no significant difference in the recovery rates of BFU-E and CFU-GM between Materials and methods thawing at 37؇C and 20؇C. These observations indicate that PBSC cryopreserved for at least 5 years by the simPreparation of peripheral blood mononuclear cells plified method can be used clinically without losing hematopoietic activity, and suggest that hematopoietic Peripheral blood mononuclear cells (PBMNC) were collected by apheresis from patients with hematologic maligactivity of the thawed PBSC may be unaffected when PBSC are infused slowly within 60 min or even when nancies in remission during hematologic recovery from consolidation chemotherapy with or without G-CSF. Aph-PBSC are thawed gradually at room temperature.
2 modified this method and evaluated its clinical use for peripheral blood stem cell transplantation (PBSCT) in 1991. A simplified method for cryopreservation at −80؇C of peripheral blood stem cells (PBSC) has been increasThey reported that rates of CFU-GM remained at more than 70% during 18 months of cryopreservation and that rapid ingly used for autologous PBSC transplantation in Japan. Although this method, using 6% hydroxyethyl and sustained trilineage engraftment was obtained in 10 patients who received marrow-ablative chemotherapy and starch (HES) and 5% dimethyl sulfoxide (DMSO) as a cryoprotectant without rate-controlled freezing, has sevautotransplantation of PBSC cryopreserved by this method. While this simplified method has several advantages eral advantages over the conventional method using 10% DMSO with rate-controlled freezing, little is such as being a quick and inexpensive procedure and less clumping of the thawed cells compared with the convenknown about effects of long-term cryopreservation for years and thawing process on hematopoietic progenitional method using rate-controlled freezing with 10% DMSO and storage in liquid nitrogen, 2 little is known about tors. We examined the recovery rates of BFU-E and CFU-GM in sample tubes cryopreserved by the simplithe influence of long-term cryopreservation for years and of the thawing process on frozen-thawed hematopoietic fied method under various conditions as follows: (1) long-term storage for 1-5 years; (2) DMSO exposure stem cells. In order to assess the clinical efficacy of this simplified for 1 h after rapid thawing; and (3) thawing at a lower temperature other than 37؇C. In our study, we found method, we investigated effects of long-term cryopreservation (1-5 years), exposure of frozen-thawed cells to that the recovery rates of BFU-E and CFU-GM were not affected by the length of cryopreservation period; DMSO, and slow thawing at room temperature on hematopoietic activity of PBSC when they were cryopreserved by they remained at more than 70% on average for 16-61 months. In our hands, a 1-h exposure to DMSO after this method. rapid thawing was not toxic for hematopoietic progenitors. Furthermore, there was no significant difference in the recovery rates of BFU-E and CFU-GM between Materials and methods thawing at 37؇C and 20؇C. These observations indicate that PBSC cryopreserved for at least 5 years by the simPreparation of peripheral blood mononuclear cells plified method can be used clinically without losing hematopoietic activity, and suggest that hematopoietic Peripheral blood mononuclear cells (PBMNC) were collected by apheresis from patients with hematologic maligactivity of the thawed PBSC may be unaffected when PBSC are infused slowly within 60 min or even when nancies in remission during hematologic recovery from consolidation chemotherapy with or without G-CSF. pended in IMDM and were used while they contained small amounts of red blood cells (Ͻ2% of the packed volume) cryopreservation at the readjusted cell concentration of 1.0 × 10 5 cells per plate in 1 ml of the ready-made culture and polymorphonuclear cells (Ͻ1% of the nucleated cells). medium (Methocult GFH4434; Stem Cell Technologies, Vancouver, Canada), which consisted of IMDM, 0.88% Cryopreservation methylcellulose, 30% FCS, 1% bovine serum albumin, 2 mm l-glutamine, 1 × 10 −4 m 2-ME, 3 U/ml rhEpo, PBMNC suspensions were gently mixed with an equal volume of cryoprotective solution consisting of 12% HES, 50 ng/ml rh stem cell factor, 10 ng/ml rhGM-CSF, 10 ng/ml rh interleukin-3, 10 ng/ml rh granulocyte colony-stimulat-10% DMSO, and 8% HSA. PBMNC samples in 1-ml volumes were stored in 2-ml freezing tubes (Assist, Tokyo, ing factor. The dishes were maintained at 37°C under the humidified atmosphere with 5% CO 2 in air. After 14 days Japan) without rate-controlled freezing in an electrical freezer at −80°C as described.
2 Twenty-five of 30 samples of culture, colonies of 40 or more cells were enumerated under an inverted microscope. from each donor were stored for 16-61 months for studying the effect of long-term cryopreservation, and the remaining Post-thawing recovery rates of BFU-E and CFU-GM were calculated as follows: five samples were stored for 1-3 months for studying the effect of the thawing process.
Recovery rate (%) = total number of BFU-E or CFU-GM after thawing total number of BFU-E or CFU-GM before freezing × 100.
Thawing
For rapid thawing after long-term cryopreservation, freezing tubes were taken from the freezer and immediately Statistical analysis placed in a 37°C water bath until ice crystals disappeared.
Linear regression analysis and Pearson's correlation coefSamples were removed from freezing tubes for trypan blue ficient were employed for statistical evaluation of results dye exclusion. Then, they were diluted slowly 10-fold with concerning long-term cryopreservation. Friedman test and IMDM containing 10% fetal calf serum (FCS; Intergen, paired t-test were used for evaluating the effect of the thawPurchase, NY, USA), and washed once in IMDM before ing process. assaying burst-forming units erythroid (BFU-E) and colony-forming units granulocyte-macrophage (CFU-GM).
To evaluate the effects of exposure to DMSO, PBMNC samples were thawed rapidly, kept at room temperature for Results 0, 15, 30 or 60 min, removed from the freezing tubes for trypan blue dye exclusion, and then diluted slowly to a 10-Long-term cryopreservation fold volume with IMDM medium containing 10% FCS, and Effects of cryopreservation periods on the cell viability and washed once in IMDM for assaying BFU-E and CFU-GM.
recovery rates of BFU-E and CFU-GM are shown in For the evaluation of the effects of thawing temperature, Figure 1 . Viability of the thawed cells showed a weak PBMNC samples were thawed at 37°C in a water bath, inverse correlation with the length of time of cryopreser-20°C at room temperature, or 4°C on ice, removed from vation (r = −0.572, P Ͻ 0.01, Figure 1a) . The viability the freezing tubes for trypan blue dye exclusion, and then decreased to approximately 80% after 5 years of cryodiluted and washed similarly for assaying BFU-E and preservation. The recovery rates of BFU-E were not affec-CFU-GM.
ted by the length of time of cryopreservation for 61 months (Figure 1b) . They remained at 91.0 ± 26.0% (mean ± s.d.), Progenitor assay but the interindividual fluctuation was wide (range 29.3-128.3%). Similarly, the recovery rates of CFU-GM were Assays for BFU-E and CFU-GM for the investigation of not affected by the length of time of cryopreservation for long-term cryopreservation were performed before and 61 months (Figure 1c) . They remained at 79.4 ± 30.6% after cryopreservation, with the use of the identical lot of (mean ± s.d.); the values ranged widely from 37.3 to FCS and the same combination of cytokines, as previously 168.4%. described.
2 Briefly, PBMNC were plated in triplicate in a 35-mm plastic culture dish (Nunc, Roskilde, Denmark) at the readjusted cell concentration of 2.0 × 10 5 cells per plate DMSO toxicity in 1 ml of IMDM containing 0.88% methylcellulose, 30% FCS, 20 ng/ml recombinant human granulocyte-macroEffects of exposure time to DMSO after rapid thawing on cell viability and recovery rates of BFU-E and CFU-GM phage colony-stimulating factor (rhGM-CSF), 1 U/ml recombinant human erythropoietin (rhEpo) and 5 × 10 −5 m are shown in Figure 2 . The mean cell viability (± s.d.) significantly decreased from 75 ± 5% (range 69-80%) to 2-mercaptoethanol (2-ME; Sigma, St Louis, MO, USA). RhGM-CSF and rhEpo were kindly provided by Kirin 63 ± 8% (range 55-75%) when the frozen-thawed cells were exposed to 5% DMSO in the cryoprotective solution Brewery (Tokyo, Japan). The dishes were maintained at 37°C in a humidified atmosphere with 5% CO 2 in air. After for 60 min after thawing (Friedman test, P Ͻ 0.01). Differences in viability between 0 and 30 min, and between 30 14 days of culture, colonies of 40 or more cells were enumerated under an inverted microscope.
and 60 min exposure times were significant respectively (P Ͻ 0.01 and Ͻ0.05 by paired t-test, Figure 2a ). By conAssays for BFU-E and CFU-GM for the investigation of the thawing process were performed before and after trast, Figures 2b and c show that recovery rates of BFU-E and CFU-GM were not influenced after 30 min or 60 min exposure to DMSO. The recovery rates of BFU-E and CFU-GM changed from 88.6 ± 19.8% to 79.1 ± 26.0%, and from 101.6 ± 36.6% to 103.6 ± 40.0%, respectively, during a 60 min exposure. These differences are not significant by either Friedman test or paired t-test (Figure 2b and c) .
Thawing temperature
Effects of thawing temperature on the cell viability and recovery rates of progenitors are shown in Figure 3 . The mean time for melting of ice crystals was 93 s at 37°C, 176 s at 20°C, and 22 min at 4°C. The cell viability was 75 ± 5% at 37°C (range, 69-80%), 68 ± 8% at 20°C (range of BFU-E were 88.6 ± 19.8 at 37°C (range, 65.7-112.3%),
78.2 ± 18.4% at 20°C (range 52.0-96.3%), and 74.1 ± 22.5% at 4°C (range 50.7-101.1%). Differences in BFU-E recovery between thawing temperatures of 37°C and 20°C, and between those of 20°C and 4°C were not significant while the difference between those of 37°C and 4°C was significant as shown in Figure 3b (P Ͻ 0.05 by paired t-test). The recovery rates of CFU-GM were 101.6 ± 36.6% at 37°C (range, 52.4-137.9%), 90.3 ± 28.3% at 20°C (range 53.7-125.2%), and 74.4 ± 22.2% at 4°C (range 42.1-97.2%). Differences in CFU-GM recovery between thawing temperatures of 37°C and 20°C were not significant, while the differences between those of 20°C and 4°C were significant as shown in Figure 3c (P Ͻ 0.05 by paired t-test).
Discussion
A simplified method of cryopreservation of PBSC was clinically evaluated in patients who received marrow ablative chemotherapy and autologous PBSCT.
2 Several advantages of this method over the conventional method have been confirmed in clinical trials; 3,4 they include a brief and inexpensive procedure, less clumping of the thawed cells, and no necessity for strictly rate-controlled freezing. However, long-term cryopreservation of PBSC by this simplified method has not been evaluated except in a report by Makino et al, 2 who investigated CFU-GM recovery after 18 months of cryopreservation. Our data indicate that the simplified method can afford long-term cryopreservation of PBSC for at least 5 years in clinical application. There was no significant decrease in recovery of hematopoietic progenitors such as BFU-E and CFU-GM though the cell viability decreased to approximately 80% after 5 years of cryopreservation. Therefore, the simplified method can be used as an alternative to the conventional method utilizing rate-controlled freezing and storage in liquid nitrogen for long-term cryopreservation of PBSC.
Although DMSO has been preferentially used as one of the most effective cryoprotectants, it interacts with hydrophobic residues of proteins, leading to denaturation and destruction of proteins. 5 Moreover, severe adverse effects such as serum hyperosmolality 6 and cardiac arrhythmia 7 have been reported in patients infused with cryopreserved stem cells. In clinical practice, to avoid direct adverse effects of DMSO or volume overload caused by the infusion of a relatively large amount of cryoprotective solution containing PBSC, slow drip infusion may be recommended. It has been reported that bone marrow progenitor cells are resistant to the toxicity induced by exposure to 10% DMSO for 2 h without cryopreservation, 8 and that bone marrow progenitor cells cryopreserved with ratecontrolled freezing are also resistant for 1 h after thawing. 9 Consistent with these observations, our data indicate that the presence of DMSO (5%) in the rapidly thawed PBSC samples for at least 60 min after thawing is not toxic to hematopoietic progenitor cells.
Rapid thawing, in which frozen cells are warmed at a by the dilution shock. 11 Leibo et al 10 have reported a major for cryopreservation of peripheral blood stem cells at −80°C increase in marrow cell viability at a warming rate of 90°C without rate-controlled freezing. Bone Marrow Transplant
